Journal of Clinical Epidemiology
Volume 52, Issue 3 , Pages 193-197 , March 1999

How Should Importance and Severity Ratings Be Combined for Item Reduction in the Development of Health Status Instruments?

  • Robert G. Marx

      Affiliations

    • Department of Surgery and Public Health Sciences, Clinical Epidemiology, and Health Research Program, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada
    • Institute for Work and Health, Toronto, Ontario, Canada
    • ,
  • Claire Bombardier

      Affiliations

    • Institute for Work and Health, Toronto, Ontario, Canada
    • Department of Medicine, Health Administration, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Sheilah Hogg-Johnson

      Affiliations

    • Institute for Work and Health, Toronto, Ontario, Canada
    • ,
  • James G. Wright

      Affiliations

    • Department of Surgery and Public Health Sciences, Clinical Epidemiology, and Health Research Program, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to: Dr. James G. Wright, The Hospital for Sick Children, 555 University Avenue, S-107, Toronto, Ontario, Canada M5G 1X8

,Accepted 6 November 1998.

References 

  1. Feinstein AR. Clinimetrics. Westford, MA: Murray Printing Company; 1987;
  2. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Can Med Assoc J. 1986;134:889–895
  3. Streiner DL, Norman GR. Health Measurement Scales. A Practical Guide to their Development and Use. Oxford: Oxford University Press; 1989;
  4. Wright JG, Feinstein AR. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol. 1992;45:1201–1218
  5. Wright JG, Rudicel S, Feinstein AR. Ask patients what they want. Evaluation of individual complaints before total hip replacement. J Bone Joint Surg. 1994;76B:229–234
  6. Guyatt GH, Berman LB, Townsend M, Pugsley OS, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778
  7. Guyatt GH, Eagle DJ, Sackett B, Willan A, Griffith L, McIlroy W, et al.  Measuring quality of life in the frail elderly. J Clin Epidemiol. 1993;46:1433–1444
  8. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77–83
  9. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation impairment of health related quality of life in asthma (Development of a questionnaire for use in clinical trials). Thorax. 1992;47:76–83
  10. Levine MN, Guyatt GH, Gent M, De Pauw S, Goodyear MD, Hryniuk WM, et al.  Quality of life in stage II breast cancer (An instrument for clinical trials). J Clin Oncol. 1988;6:1798–1810
  11. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis. 1985;38:27–36
  12. Hudak PL, Amadio PC, Bombardier CB, Beaton D, Cole D, Davis A, et al.  Development of an upper extremity outcome measure (The DASH (disabilities of the arm, shoulder and hand)). Am J Ind Med. 1996;29:602–608
  13. Wright JG, Young NL. The patient specific index (Asking patients what they want). J Bone Joint Surg. 1997;79A:974–983
  14. Stavig GR. Monotonic measures of agreement for ranked data. Br J Math Stat Psychol. 1984;37:283–287

PII: S0895-4356(98)00169-3

Journal of Clinical Epidemiology
Volume 52, Issue 3 , Pages 193-197 , March 1999

Article Tools